Mark Jit

Summary

Affiliation: Health Protection Agency
Country: UK

Publications

  1. pmc Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocol
    Luis R Carrasco
    Department of Statistics and Applied Probability, National University of Singapore, Singapore, Singapore
    Emerg Themes Epidemiol 10:3. 2013
  2. pmc Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
    Rohan Deogaonkar
    Health Economics Unit, University of Birmingham, UK
    BMC Public Health 12:878. 2012
  3. pmc Enzymes provide demographers with food for thought
    Mark Jit
    is in the Modelling and Economics Unit, Health Protection Agency, London, UK, and the Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
    elife 1:e00340. 2012
  4. pmc Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
    Maarten J Postma
    Unit of PharmacoEpidemiology and PharmacoEconomics PE2, Department of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
    BMC Med 9:84. 2011
  5. doi request reprint The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency Centre for Infections, London, UK
    J Infect 61:114-24. 2010
  6. doi request reprint The cost-effectiveness of rotavirus vaccination in Armenia
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
    Vaccine 29:9104-11. 2011
  7. doi request reprint The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales
    Mark Jit
    Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
    Vaccine 29:115-22. 2010
  8. pmc Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
    Mark Jit
    Health Protection Agency, London NW9 6BT, UK
    BMJ 343:d5775. 2011
  9. doi request reprint Estimating progression rates for human papillomavirus infection from epidemiological data
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency Centre for Infections, London, United Kingdom
    Med Decis Making 30:84-98. 2010
  10. pmc Economic evaluation of human papillomavirus vaccination in the United Kingdom
    Mark Jit
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London NW9 6BT
    BMJ 337:a769. 2008

Collaborators

Detail Information

Publications46

  1. pmc Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocol
    Luis R Carrasco
    Department of Statistics and Applied Probability, National University of Singapore, Singapore, Singapore
    Emerg Themes Epidemiol 10:3. 2013
    ..The volume of influenza pandemic modelling studies has increased dramatically in the last decade. Many models incorporate now sophisticated parameterization and validation techniques, economic analyses and the behaviour of individuals...
  2. pmc Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
    Rohan Deogaonkar
    Health Economics Unit, University of Birmingham, UK
    BMC Public Health 12:878. 2012
    ..Measuring broader, long-term effects of vaccination on productivity and externalities could provide a more complete picture of the value of vaccines...
  3. pmc Enzymes provide demographers with food for thought
    Mark Jit
    is in the Modelling and Economics Unit, Health Protection Agency, London, UK, and the Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
    elife 1:e00340. 2012
    ..Life expectancy has increased by 20 years since the middle of the last century, but children under five have fared better than adult males...
  4. pmc Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
    Maarten J Postma
    Unit of PharmacoEpidemiology and PharmacoEconomics PE2, Department of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
    BMC Med 9:84. 2011
    ....
  5. doi request reprint The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency Centre for Infections, London, UK
    J Infect 61:114-24. 2010
    ..To determine the risk of various kinds of sequelae in survivors of meningitis due to Streptococcus pneumoniae, as well as the influence of co-factors such as study design, study population and treatment on this risk...
  6. doi request reprint The cost-effectiveness of rotavirus vaccination in Armenia
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
    Vaccine 29:9104-11. 2011
    ..Vaccination may still be "very cost-effective" if less favourable assumptions are used regarding vaccine price and disease incidence, as long as DALYs are not age-weighted...
  7. doi request reprint The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales
    Mark Jit
    Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
    Vaccine 29:115-22. 2010
    ..Key sources of uncertainty are the cost of vaccine delivery and the quality of life detriment due to a clinically apparent episode of confirmed influenza. The cost of vaccine purchase itself is relatively low...
  8. pmc Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
    Mark Jit
    Health Protection Agency, London NW9 6BT, UK
    BMJ 343:d5775. 2011
    ....
  9. doi request reprint Estimating progression rates for human papillomavirus infection from epidemiological data
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency Centre for Infections, London, United Kingdom
    Med Decis Making 30:84-98. 2010
    ..The scenarios and parameter sets that produce the best fit to available epidemiological data provide a basis for modeling the natural history of HPV infection and disease...
  10. pmc Economic evaluation of human papillomavirus vaccination in the United Kingdom
    Mark Jit
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London NW9 6BT
    BMJ 337:a769. 2008
    ..To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom...
  11. pmc Prevalence of human papillomavirus antibodies in young female subjects in England
    M Jit
    Immunisation Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK
    Br J Cancer 97:989-91. 2007
    ..7% (95% confidence intervals 9.0-12.3) for human papillomavirus (HPV) 6, 2.7% (1.8-3.6) for HPV 11, 11.9% (10.2-13.6) for HPV 16, 4.7% (3.5-5.8) for HPV 18, and 20.7% (18.6-22.7) for any of the four types...
  12. ncbi request reprint Estimating the number of deaths with rotavirus as a cause in England and wales
    Mark Jit
    Modelling and Economics Unit, Immunisation Department, Health Protection Agency, London, UK
    Hum Vaccin 3:23-6. 2007
    ..The two methods gave estimates of 3.8 and 3.2 rotavirus deaths a year respectively...
  13. doi request reprint Modelling the epidemiology of infectious diseases for decision analysis: a primer
    Mark Jit
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London, UK
    Pharmacoeconomics 29:371-86. 2011
    ....
  14. pmc Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and Wales
    Yoon Hong Choi
    Health Protection Services Colindale, Health Protection Agency, London, United Kingdom
    PLoS ONE 7:e39927. 2012
    ....
  15. pmc Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
    BMC Med 11:23. 2013
    ..This report describes the consensus of an expert group convened by the World Health Organization, prioritizing key issues to be addressed when considering economic analyses to support HPV vaccine introduction in these countries...
  16. pmc 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?
    Yoon Hong Choi
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
    PLoS ONE 6:e26190. 2011
    ..However, recent surveillance data show a more rapid replacement of PCV7 IPD cases by non-PCV7 IPD cases than was seen in the US...
  17. pmc Oral Human Papillomavirus Infection in Men Who Have Sex with Men: A Systematic Review and Meta-Analysis
    Eleanor M King
    Research Department of Infection and Population Health, University College London, WC1E 6JB, London, United Kingdom
    PLoS ONE 11:e0157976. 2016
    ..The impact of HPV vaccination has, to date, largely focussed on anogenital outcomes. Vaccination of MSM in the UK has been recommended and, if implemented, baseline estimates of oral HPV prevalence will be useful...
  18. doi request reprint The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Services, Colindale, Health Protection Agency, London NW9 5EQ, UK
    Vaccine 30:7205-13. 2012
    ....
  19. doi request reprint Health and economic impact of the seasonal influenza vaccination programme in England
    Marc Baguelin
    Health Protection Agency, United Kingdom
    Vaccine 30:3459-62. 2012
    ..The seasonal influenza vaccination programme in England targets individuals over 65 years old and in clinical risk groups...
  20. doi request reprint The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy
    Esther van Kleef
    London School of Hygiene and Tropical Medicine, London, United Kingdom Modelling and Economics Unit, Public Health England, London, United Kingdom Electronic address
    Vaccine 34:5562-5570. 2016
    ..This study performed a model-based evaluation of the effectiveness of different CDI vaccination strategies, within the context of existing infection prevention and control strategies such as antimicrobial stewardship...
  21. doi request reprint Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
    Yoon Hong Choi
    Immunisation Department, HPA Centre for Infections, 61 Colindale Avenue, Colindale, London, United Kingdom
    Vaccine 28:4091-102. 2010
    ..The marginal benefit of vaccinating boys depends on the degree of protection achieved by vaccinating girls...
  22. pmc A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls
    Eve Draper
    Virus Reference Department, Health Protection Agency, London, United Kingdom
    PLoS ONE 8:e61825. 2013
    ....
  23. pmc Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation
    Mark Jit
    Health Protection Agency, London NW9 5EQ, UK
    BMJ 343:d5376. 2011
    ..To assess the cost effectiveness of the Find and Treat service for diagnosing and managing hard to reach individuals with active tuberculosis...
  24. doi request reprint Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation
    Marc Baguelin
    Centre for Infections, Health Protection Agency, United Kingdom
    Vaccine 28:2370-84. 2010
    ..In countries where the epidemic is not so far advanced vaccination of children may be cost-effective. Similar, detailed, real-time modelling and economic studies could help to clarify the situation...
  25. doi request reprint Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model
    Yoon Hong Choi
    Health Protection Services Colindale, Health Protection Agency, London, United Kingdom
    Vaccine 30:3383-8. 2012
    ..Misattribution of the causal HPV type for a particular abnormality may give rise to an apparent increase in disease due to non-vaccine HPV types following vaccination ("unmasking")...
  26. doi request reprint What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patterns
    Alessia Melegaro
    Modelling and Economics Unit, Health Protection Agency, Centre for Infections, London, UK
    Epidemics 3:143-51. 2011
    ..We observe similar patterns in each of the countries analysed, suggesting that there are consistent biological mechanisms at work...
  27. doi request reprint Modelling borderline and mild dysplasia associated with HPV 6 and 11 infection
    Ruth Chapman
    Immunization Department, Centre for Infections, Health Protection Agency, London, United Kingdom
    Vaccine 29:2881-6. 2011
    ..We investigate the contribution of HPV types 6/11 to abnormal smears and associated costs in England...
  28. doi request reprint Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and Wales
    Joke Bilcke
    Centre for Health Economics Research and Modeling of Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium JB, LW Department of Infectious Diseases Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK JB, HJ, WJE, MJ Modelling and Economics Unit, Public Health England, London, UK RC, MJ Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK CA Complex Systems in Biology Group, Centre for Vascular Research, UNSW Australia, Sydney, New South Wales, Australia DC Department of Mathematics and Computer Science, University of Antwerp, Antwerp, Belgium LW Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Diepenbeek, Belgium LW Department of Applied Sciences and Health, Coventry University, Coventry, UK MC JB and RC and CA and DC contributed equally
    Med Decis Making 35:633-47. 2015
    ..However, most of these models fail to account for the uncertainty about several vaccine characteristics and the mechanism of vaccine action...
  29. pmc Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance
    Eleanor M King
    Research Department of Infection and Population Health, University College London, London, UK
    Sex Transm Infect 91:284-6. 2015
    ..Such data are important to improve our understanding of the epidemiology of oral HPV and the potential use of vaccines to prevent oropharyngeal cancers...
  30. pmc Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
    Mark Jit
    Modelling and Economics Unit, Public Health England, London NW9 5EQ, UK Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London
    BMJ 350:g7584. 2015
    ..To investigate the incremental cost effectiveness of two dose human papillomavirus vaccination and of additionally giving a third dose...
  31. pmc The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
    PLoS ONE 6:e17030. 2011
    ..Such a measure would allow comparison with other diseases and assessment of the cost-effectiveness of pandemic control measures...
  32. doi request reprint Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men
    Allen Lin
    Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
    Clin Infect Dis . 2016
    ..They also benefit less from herd protection than heterosexual males in settings with female-only HPV vaccination...
  33. pmc Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot
    Katherine Atkins
    Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
    BMJ Open 6:e009739. 2016
    ..To evaluate the effectiveness and cost of the pan-London pharmacy initiative, a programme that allows administration of seasonal influenza vaccination to eligible patients at pharmacies...
  34. doi request reprint Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
    Mark Jit
    Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK Modelling and Economics Unit, Public Health England, London, UK
    Lancet Glob Health 2:e406-14. 2014
    ..We aimed to develop and validate a simple generic model of such effects that could be used and understood in a range of settings with little external support...
  35. doi request reprint Two-dose strategies for human papillomavirus vaccination: how well do they need to protect?
    Mark Jit
    Modelling and Economics Unit, Public Health England, London NW9 5EQ, United Kingdom Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom Electronic address
    Vaccine 32:3237-42. 2014
    ..Two-dose human papillomavirus (HPV) vaccine schedules may provide short-term protection but their long-term population impact is unknown...
  36. doi request reprint Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all?
    Koh Jun Ong
    HIV STI Department, National Infection Service, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK
    Sex Transm Infect . 2016
    ....
  37. pmc The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
    Stefan Flasche
    London School of Hygiene and Tropical Medicine, London, United Kingdom
    PLoS Med 13:e1002181. 2016
    ..These predictions were conducted for the World Health Organization to inform their recommendations on optimal use of this vaccine...
  38. pmc Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
    Mark Jit
    Modelling and Economics Unit, Public Health England, 61 Colindale Avenue, London, NW9 6BT, UK
    Appl Health Econ Health Policy 14:245-52. 2016
    ..The scope of an economic evaluation must consider the budget from which vaccines are funded, and the decision-maker's stated aims for that spending to achieve. ..
  39. pmc The broader economic impact of vaccination: reviewing and appraising the strength of evidence
    Mark Jit
    Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK
    BMC Med 13:209. 2015
    ..Broader economic benefits around childhood development, household behaviour, and macro-economic indicators are increasingly important, but the evidence linking immunization to such benefits is unclear...
  40. pmc Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization
    Mark Jit
    Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK Modelling and Economics Unit, Public Health England, London, UK Electronic address
    Vaccine 33:A233-9. 2015
    ..However, the impact and cost-effectiveness of the Expanded Programme on Immunization (EPI) as a whole has never been assessed on a country level...
  41. pmc Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency, London, UK
    BMC Med 9:54. 2011
    ..To provide information about the feasibility of using such models in a developing country setting, we evaluated models of HPV vaccination in terms of their capacity, requirements, limitations and comparability...
  42. pmc Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infection
    Esther van Kleef
    London School of Hygiene and Tropical Medicine, London, United Kingdom Public Health England, Colindale, London, United Kingdom
    PLoS ONE 9:e99860. 2014
    ..However, this evidence was limited to one geographic area. We aimed to investigate the level of symptomatic CDI transmission in hospitals located across England from 2008 to 2012...
  43. ncbi request reprint A stochastic model to evaluate options for antenatal genetic screening
    Steve Gallivan
    Clinical Operational Research Unit, Department of Mathematics, University College London, Gower Street, London, UK
    Health Care Manag Sci 9:111-24. 2006
    ..The model has been implemented as a computer package that can be used to inform decisions made by health care planners...
  44. ncbi request reprint Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination
    M Jit
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London, United Kingdom
    Vaccine 25:3971-9. 2007
    ..Two rotavirus vaccines (RotaTeq and Rotarix) have recently completed clinical trials. We investigated whether routine infant immunisation with either vaccine can be cost effective...
  45. ncbi request reprint Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease
    J P Harris
    Environmental and Enteric Diseases Department, Centre for Infections, Health Protection Agency, United Kingdom
    Vaccine 25:3962-70. 2007
    ..This study provides a sound basis on which to make this assessment and serves as a baseline against which any reductions that do occur if vaccination is introduced can be measured against...
  46. ncbi request reprint Restructuring routine elective services to reduce overall capacity requirements within a local health economy
    Martin Utley
    Clinical Operational Research Unit, University College London, Gower Street, London WC1E 6BT, UK
    Health Care Manag Sci 11:240-7. 2008
    ..As an illustration of the analysis, we present results obtained using data concerning urological services, for which there would seem to be benefits associated with the introduction of a TC in only a limited range of circumstances...